MTA3 and cancer: Thus, we have identified two types of transcripts: (a) transcripts that are not expressed in normal conditions and are gained in cancer (e.g. CIT, CCNE1) and (b) transcripts that gain an additional cancer-associated transcript (e.g. MTA3, ZFHX3).